Weatherly International shines bright as small caps go higher
UK small caps were outshining big caps in early deals with copper junior Weatherly International PLC the runaway gainer.
Company
LON:OPTI
OptiBiotix Health Plc is a life sciences company operating in one of the most progressive areas of biotechnological research. Developing and commercialising technologies that modulate the human microbiome – the collective genome of the microbes in the body – the company identifies and develops prebiotic formulations and compounds for use in food ingredients and supplements that can impact on human physiology and metabolism, deriving potential health benefits.
574 stories · page 6 of 6
UK small caps were outshining big caps in early deals with copper junior Weatherly International PLC the runaway gainer.
There's a flurry of interesting small cap firms reporting this week, alongside AIM internet retail biggie ASOS....
Archive
Better news for Westminster group, a 'transformational' year for Alliance Pharma and Victoria Oil & Gas secures government approval.
The supplement could reduce cholesterol and blood pressure
Archive
Silence Therapeutics new drug's oncology potential, deferral of debt for Aureus Mining and strong trading for PureCircle.
DSM is one of the world's leading suppliers of nutritional ingredients
Chief of life sciences group OptiBiotix Health PLC Stephen OHara says increased rates of global obesity should boost demand for his firm's products.
OptiBiotix Health PLC, the life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, has signed a second collaboration agreement with an arm of the Spanish National Research Council.
Archive
Sirius Minerals' "world class" North Yorkshire project, update on Aureus and Allergy Therapeutics to lose finance director.
The company is using its knowledge of this emerging area of science to develop treatments that tackle cholesterol and obesity.
Spector’s appointment creates opportunities to collaborate and additional insight into the role of the microbiome in health and disease, Optibiotix highlighted.
Archive
After briefly venturing back above 6,000, the Footsie saw its gains trimmed as US markets turned lower.
If everyone could be as active as the York-based outfit there would not be such a pressing demand for its products.
Investors shrug off 'We're done for' predictions to push shares higher
Premier Oil is eyeing up the North Sea assets of German utility company Eon, according to reports.
The SlimBiome product could be commercialised by KSF Acquisition, the company behind the SlimFast brand in the UK, Ireland and Germany.
Read it and weep blue-chip backers: the AIM 100 trounced the FTSE 100 in 2015, and sported some sensational performances.
Archive
FTSE100, the UK's premier share index, closed out the year around 25 points lower in a curtailed trading day...
Archive
Atlantic Coal mulls leaving AIM while Caledonia Mining proposes moving its HQ to Jersey
Investments and investor services
The FTSE100 ended the day almost 15 points lower to 6,223.
Investments and investor services
Sunrise Resources, Optibiotix Health and ITM Power also had news out
The FTSE100 was around 30 points higher at 6,267 with aerospace engine maker Rolls Royce leading the way.
Investments and investor services
The Footsie rose 30.9 points to 6269.19 while mainland European markets also gained
Life sciences firm OptiBiotix Health has raised £1.5mln in a placing to develop its growing business further....
Investments and investor services
Anglo Asian Mining, Kefi Minerals and Andes Energia also has news out today
Life sciences firm OptiBiotix Health has struck a development deal with Italian group Centro Sperimentale Del Latte (CSL)....
Three life sciences firms with products aimed at the consumer end of the market were to the fore this week
Investments and investor services
Here are the Proactive Investors small cap news highlights for Tuesday November 3.
OptiBiotix Health has filed two new patents relating to its cholesterol-reducing product.
OptiBiotix (LON:OPTI) chief Stephen OHara today highlighted a new report, which says the human microbiome market is expected to reach a whopping US$658 million by 2023
Investments and investor services
China and the ECB left investors in a positive mood at the end of the week
Investments and investor services
Pharma companies and energy firms were in the news today...
China has cheered the market, especially investors in resource stocks, by announcing further stimulus measures
Investments and investor services
Below are the main news-driven share price movements at 4pm.
Investments and investor services
Footsie broke above 6400 and mainland European bourses also rose
OptiBiotix is developing a range of non-digestible natural healthy sugars with zero calories that could help tackle an epidemic estimated to be costing the NHS £5.1bn annually.
Archive
A mixed news bag to end the week. Here is a summary....
"Strong intellectual product and scientific advances will strengthen OptiBiotix’s position at the bargaining table," Hybridan said.
Archive
The end of quarter is approaching so companies were rushing out end-June trading updates, leading to a very heavy news day.
The product is now undergoing pilot scale manufacturing studies.
Archive
Crude price talk was again in focus, but there was a smattering of corporate news dfrom the sector too....
As the politicos and pundits eagerly await the result of the Labour leadership vote, attracting interest on the net was among other things, the oil price and pub chain JD Wetherspoon..
Action group hopes to take NWOG into medical technology
The last six months have seen the company make significant progress.
Investments and investor services
Traders cheered by signs that cost of borrowing may not rise until 2016
Archive
A fairly quiet day on the small cap front, if not elsewhere, but there were some notable announcements.
Unlike other products on the market, Optibiotix says this new supplement can also reduce the amount of cholesterol produced by the body.
Archive
Rambler Metals rose after it completed its pre-feasibility study.
OptiBiotix is described as a “sweet opportunity” by the research house Hybridan, which recently started coverage of the AIM-listed company
Archive
A number of resource companies have successfully raised fresh capital today, while another has been on a cost-cutting drive.
Investments and investor services
Primark's growth makes Associated British Foods' name more of a misnomer year-by-year
OptiBiotix Health has inked an agreement with a renowned compound analysis centre in Madrid, which furthers its work on developing novel sugars.
Investments and investor services
UK investors shrugged off concerns over Greece to follow US equities higher in the afternoon session
A firm start on Wall Street encouraged a rally in London
Venture Life Group announced yesterday it is teaming up with Optibiotix Health.
Archive
A treatment for a rare form of haemophilia developed with the help of Abzena’s screening technology has been granted orphan status by the US regulatory authorities. It was one of a number of pharma stories to come out today.
Two of AIM's newest healthcare firms are teaming up to bring functional foods and supplements to a fit and active older generation.
OptiBiotix has create a cholesterol reducing supplement it is trialling with a large multinational company.
OptiBiotix Health hief executive Stephen O'Hara told Proactive today that the new patents received concerning its OptiBiotic platform strengthened the firm's position and potential value.
Archive